Capula Management’s Boston Scientific BSX Stock Holding History

Capula Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,300	Closed	-$315K	–	1091
2025 Q4	$315K	Sell	3,300 -19,700	-86%	-$1.93M	﹤0.01%	481
2025 Q3	$2.25M	Buy	23,000 +19,600	+576%	+$2.03M	0.01%	222
2025 Q2	$365K	Sell	3,400 -900	-21%	-$91.1K	﹤0.01%	270
2025 Q1	$434K	Buy	+4,300	New	+$433K	﹤0.01%	325
2023 Q2	–	Sell	-136,800	Closed	-$6.84M	–	466
2023 Q1	$6.84M	Sell	136,800 -3,200	-2%	-$151K	0.08%	198
2022 Q4	$6.48M	Buy	+140,000	New	+$6.06M	0.09%	226
2021 Q1	–	Sell	-39,800	Closed	-$1.43M	–	493
2020 Q4	$1.43M	Buy	+39,800	New	+$1.43M	0.07%	192
2020 Q3	–	Sell	-30,000	Closed	-$1.05M	–	160
2020 Q2	$1.05M	Buy	+30,000	New	+$1.08M	0.04%	246
2020 Q1	–	Sell	-44,200	Closed	-$2M	–	366
2019 Q4	$2M	Sell	44,200 -69,400	-61%	-$2.9M	0.04%	259
2019 Q3	$4.62M	Buy	+113,600	New	+$4.81M	0.1%	171

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capula Management's BSX Position: Q1 2026 in Review

Capula Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 967 shares — an estimated $92.2K sold.

Capula Management first reported a position in BSX in Q3 2019 and held it in 8 quarters. The position peaked at $821K in Q3 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Capula Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Capula Management sold 967 Boston Scientific shares in Q1 2026, an estimated $92.2K.
Capula Management first reported a position in Boston Scientific in Q3 2019 and held it in 8 quarters.
Capula Management's Boston Scientific position peaked at $821K in Q3 2019.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.